Laureate Education, Inc. (LAUR) stock
Close on Nov 16, 2026Market cap $4.69BP/E 12.7Yield –
Earnings
Laureate Education's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Laureate Education's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 18, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026before the open | $485.10M | +21.2% | $0.73 | $0.52 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 30, 2026before the open | $615.90M | +17.5% | $0.98 | $1.00 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026before the open | $272.60M | +15.4% | -$0.15 | -$0.17 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 19, 2026before the open | $541.40M | +27.9% | $1.17 | $0.76 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 30, 2025before the open | $400.20M | +8.6% | $0.23 | $0.25 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 31, 2025before the open | $524.20M | +5.0% | $0.65 | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 1, 2025before the open | $236.20M | -14.2% | -$0.13 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 20, 2025before the open | $423.40M | +3.4% | $0.62 | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 31, 2024before the open | $368.60M | +2.0% | $0.56 | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 1, 2024before the open | $499.20M | +8.0% | $0.83 | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024before the open | $275.40M | +9.6% | -$0.07 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 22, 2024before the open | $409.40M | +18.2% | $0.26 | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 2, 2023before the open | $361.50M | +20.1% | $0.23 | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023before the open | $462.10M | +19.9% | $0.35 | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 4, 2023before the open | $251.30M | +19.9% | -$0.17 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 23, 2023before the open | $346.30M | +16.7% | $0.25 | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022before the open | $301.00M | +12.4% | $0.19 | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022before the open | $385.40M | – | $0.25 | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022before the open | $209.60M | – | -$0.25 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 24, 2022before the open | $296.70M | – | $0.15 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 4, 2021before the open | $267.70M | – | $1.94 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 5, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 6, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 25, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 5, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Laureate Education's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenuesGAAP | FY2026 | $1.92B – $1.93B | – | New | Oct 29, 2026 |
| Revenues | FY2026 | $1.92B – $1.93B | $1.89B – $1.91B | Raised | Jul 30, 2026 |
| RevenuesGAAP | FY2026 | $1.89B – $1.91B | – | New | Feb 19, 2026 |
| Revenues growth (as-reported basis) | FY2026 | +11% – +12% | – | New | Apr 30, 2026 |
| Revenues growth (constant currency basis)non-GAAP | FY2026 | +6% – +7% | – | New | Apr 30, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $593.00M – $599.00M | – | New | Oct 29, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $593.00M – $599.00M | $583.00M – $593.00M | Raised | Jul 30, 2026 |
| Adjusted EBITDA growth (as-reported basis)non-GAAP | FY2026 | +12% – +14% | – | New | Apr 30, 2026 |
| Adjusted EPSnon-GAAP | FY2026 | $2.04 – $2.10 | – | New | Oct 29, 2026 |
| Adjusted EPSnon-GAAP | FY2026 | $2.04 – $2.10 | $2.00 – $2.08 | Raised | Jul 30, 2026 |
| Adjusted EPS growth (as-reported basis)non-GAAP | FY2026 | +16% – +21% | – | New | Apr 30, 2026 |
| Total enrollments | FY2026 | 518,000 – 523,000 | – | New | Oct 29, 2026 |
| Total enrollments | FY2026 | 518,000 – 523,000 | 516,000 – 521,000 | Raised | Jul 30, 2026 |
| Total enrollments growth | FY2026 | +4% – +5% | – | New | Apr 30, 2026 |
Guidance vs results
The last range Laureate Education gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $1.68B – $1.69B | $1.70BΣ4Q | Above range |
Guidance history
Every forecast Laureate Education put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 29, 2026 | Adjusted EBITDA | FY2026 | $593.00M – $599.00M | New |
| Oct 29, 2026 | Adjusted EPS | FY2026 | $2.04 – $2.10 | New |
| Oct 29, 2026 | Total enrollments | FY2026 | 518,000 – 523,000 | New |
| Oct 29, 2026 | Revenues | FY2026 | $1.92B – $1.93B | New |
| Jul 30, 2026 | Adjusted EBITDA | FY2026 | $593.00M – $599.00M | Raised |
| Jul 30, 2026 | Adjusted EPS | FY2026 | $2.04 – $2.10 | Raised |
| Jul 30, 2026 | Total enrollments | FY2026 | 518,000 – 523,000 | Raised |
| Jul 30, 2026 | Revenues | FY2026 | $1.92B – $1.93B | Raised |
| Apr 30, 2026 | Adjusted EBITDA growth (as-reported basis) | FY2026 | +12% – +14% | New |
| Apr 30, 2026 | Adjusted EBITDA growth (constant currency basis) | FY2026 | +7% – +9% | Lowered |
| Apr 30, 2026 | Adjusted EBITDA | FY2026 | $583.00M – $593.00M | Reaffirmed |
| Apr 30, 2026 | Adjusted EPS growth (as-reported basis) | FY2026 | +16% – +21% | New |
| Apr 30, 2026 | Adjusted EPS | FY2026 | $2.00 – $2.08 | Raised |
| Apr 30, 2026 | Total enrollments | FY2026 | 516,000 – 521,000 | Reaffirmed |
| Apr 30, 2026 | Total enrollments growth | FY2026 | +4% – +5% | New |
| Apr 30, 2026 | Revenues growth (as-reported basis) | FY2026 | +11% – +12% | New |
| Apr 30, 2026 | Revenues growth (constant currency basis) | FY2026 | +6% – +7% | New |
| Apr 30, 2026 | Revenues | FY2026 | $1.89B – $1.91B | New |
| Feb 19, 2026 | Adjusted EBITDA | FY2026 | $583.00M – $593.00M | New |
| Feb 19, 2026 | Adjusted earnings per share (Adjusted EPS) | FY2026 | $1.95 – $2.03 | New |
| Feb 19, 2026 | Total enrollments | FY2026 | 516,000 – 521,000 | New |
| Feb 19, 2026 | Revenues | FY2026 | $1.89B – $1.91B | New |
| Oct 30, 2025 | Adjusted EBITDA | FY2025 | $508.00M – $512.00M | New |
| Oct 30, 2025 | Total enrollments | FY2025 | 494,000 | New |
| Oct 30, 2025 | Revenues | FY2025 | $1.68B – $1.69B | New |
| Jul 31, 2025 | Adjusted EBITDA | FY2025 | $489.00M – $496.00M | Raised |
| Jul 31, 2025 | Total enrollments | FY2025 | 491,000 – 495,000 | Reaffirmed |
| Jul 31, 2025 | Revenues | FY2025 | $1.62B – $1.63B | New |
| May 1, 2025 | Adjusted EBITDA growth (as-reported basis) | FY2025 | +5% – +7% | Raised |
| May 1, 2025 | Adjusted EBITDA growth (organic constant currency basis) | FY2025 | +11% – +13% | Reaffirmed |
| May 1, 2025 | Adjusted EBITDA | FY2025 | $473.00M – $480.00M | Raised |
| May 1, 2025 | Total enrollments | FY2025 | 491,000 – 495,000 | Raised |
| May 1, 2025 | Total enrollments growth | FY2025 | +4% – +5% | Reaffirmed |
| May 1, 2025 | Revenues growth (as-reported basis) | FY2025 | 0% – +1% | New |
| May 1, 2025 | Revenues growth (organic constant currency basis) | FY2025 | +6% – +7% | Lowered |
| May 1, 2025 | Revenues growth (organic constant currency basis excluding campus consolidations) | FY2025 | +7% – +8% | Raised |
| May 1, 2025 | Revenues | FY2025 | $1.56B – $1.58B | Raised |
| Feb 20, 2025 | Adjusted EBITDA growth on an as-reported basis | FY2025 | +4% – +6% | New |
| Feb 20, 2025 | Adjusted EBITDA growth on an organic constant currency basis | FY2025 | +11% – +13% | New |
| Feb 20, 2025 | Adjusted EBITDA | FY2025 | $467.00M – $477.00M | New |
| Feb 20, 2025 | Total enrollments | FY2025 | 489,000 – 495,000 | New |
| Feb 20, 2025 | Total enrollments growth | FY2025 | +4% – +5% | New |
| Feb 20, 2025 | Revenues growth on an organic constant currency basis | FY2025 | +6% – +7% | New |
| Feb 20, 2025 | Revenues growth on an organic constant currency basis excluding the impact from campus consolidations | FY2025 | +7% – +8% | Raised |
| Feb 20, 2025 | Revenues | FY2025 | $1.55B – $1.57B | New |
| Oct 31, 2024 | Adjusted EBITDA growth as-reported | FY2024 | +7% – +8% | New |
| Oct 31, 2024 | Adjusted EBITDA growth organic constant currency | FY2024 | +9% – +10% | New |
| Oct 31, 2024 | Adjusted EBITDA | FY2024 | $447.00M – $451.00M | Raised |
| Oct 31, 2024 | Total enrollments | FY2024 | 470,000 | Narrowed |
| Oct 31, 2024 | Total enrollments growth | FY2024 | +5% | New |
| Oct 31, 2024 | Revenues growth as-reported | FY2024 | +5% | New |
| Oct 31, 2024 | Revenues growth organic constant currency | FY2024 | +7% | New |
| Oct 31, 2024 | Revenues | FY2024 | $1.55B – $1.56B | New |
| Aug 1, 2024 | Adjusted EBITDA | FY2024 | $441.00M – $451.00M | Lowered |
| Aug 1, 2024 | Total enrollments | FY2024 | 467,000 – 473,000 | Reaffirmed |
| Aug 1, 2024 | Revenues | FY2024 | $1.55B – $1.57B | Lowered |
| May 2, 2024 | Adjusted EBITDA | FY2024 | $446.00M – $456.00M | Raised |
| May 2, 2024 | Total enrollments | FY2024 | 467,000 – 473,000 | Reaffirmed |
| May 2, 2024 | Revenues | FY2024 | $1.57B – $1.58B | Raised |
| Feb 22, 2024 | Adjusted EBITDA | FY2024 | $441.00M – $451.00M | New |
| Feb 22, 2024 | Total enrollments | FY2024 | 467,000 – 473,000 | New |
| Feb 22, 2024 | Revenues | FY2024 | $1.55B – $1.57B | New |
| Nov 2, 2023 | Adjusted EBITDA | FY2023 | $410.00M – $416.00M | Lowered |
| Nov 2, 2023 | Total enrollments | FY2023 | 447,000 | Lowered |
| Nov 2, 2023 | Revenues | FY2023 | $1.46B – $1.47B | Lowered |
| Aug 3, 2023 | Adjusted EBITDA | FY2023 | $419.00M – $427.00M | Raised |
| Aug 3, 2023 | Total enrollments | FY2023 | 447,000 – 455,000 | Reaffirmed |
| Aug 3, 2023 | Revenues | FY2023 | $1.48B – $1.50B | Raised |
| May 4, 2023 | Adjusted EBITDA | FY2023 | $398.00M – $406.00M | Raised |
| May 4, 2023 | Total enrollments | FY2023 | 447,000 – 455,000 | Reaffirmed |
| May 4, 2023 | Revenues | FY2023 | $1.41B – $1.43B | Raised |
| Feb 23, 2023 | Adjusted EBITDA | FY2023 | $387.00M – $397.00M | New |
| Feb 23, 2023 | Total enrollments | FY2023 | 447,000 – 455,000 | New |
| Feb 23, 2023 | Revenues | FY2023 | $1.37B – $1.40B | New |
| Nov 3, 2022 | Adjusted EBITDA | FY2022 | $331.00M – $337.00M | Raised |
| Nov 3, 2022 | Total enrollments | FY2022 | 420,000 – 423,000 | Raised |
| Nov 3, 2022 | Revenues | FY2022 | $1.22B – $1.23B | Raised |
| Aug 4, 2022 | Adjusted EBITDA | FY2022 | $329.00M – $337.00M | Raised |
| Aug 4, 2022 | Total enrollments | FY2022 | 413,000 – 419,000 | Raised |
| Aug 4, 2022 | Revenues | FY2022 | $1.21B – $1.22B | Raised |
| May 5, 2022 | Adjusted EBITDA | FY2022 | $326.00M – $334.00M | Raised |
| May 5, 2022 | Total enrollments | FY2022 | 410,000 – 416,000 | Raised |
| May 5, 2022 | Revenues | FY2022 | $1.19B – $1.21B | Raised |
| Feb 24, 2022 | Adjusted EBITDA | FY2022 | $320.00M – $330.00M | New |
| Feb 24, 2022 | Total enrollments | FY2022 | 405,000 – 415,000 | New |
| Feb 24, 2022 | Revenues | FY2022 | $1.17B – $1.19B | New |
| Nov 4, 2021 | Adjusted EBITDA | FY2021 | $247.00M – $253.00M | New |
| Nov 4, 2021 | Total enrollments | FY2021 | 385,000 | New |
| Nov 4, 2021 | Revenues | FY2021 | $1.08B – $1.09B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Laureate Education filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?